within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G01A_AntiinfectivesAndAntisepticsExclCombinationsWithCorticosteroids.G01AF07_Isoconazole;

model Isoconazole
  extends Pharmacolibrary.Drugs.ATC.G.G01AF07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>G01AF07</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Isoconazole is an imidazole class antifungal agent primarily used topically to treat a variety of fungal infections, including dermatomycoses and vulvovaginal candidiasis. Its main mechanism is inhibition of ergosterol synthesis, compromising the fungal cell membrane. It is approved and used in several countries, especially in topical formulations.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for isoconazole following typical topical use in adult healthy individuals since no direct human pharmacokinetic data are available in the literature.</p><h4>References</h4><ol><li><p>Lademann, J, et al., &amp; Seifert, S (2012). Non-invasive analysis of penetration and storage of Isoconazole nitrate in the stratum corneum and the hair follicles. <i>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</i> 80(3) 615–620. DOI:<a href=\"https://doi.org/10.1016/j.ejpb.2011.12.013\">10.1016/j.ejpb.2011.12.013</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22285524/\">https://pubmed.ncbi.nlm.nih.gov/22285524</a></p></li><li><p>Dykes, PJ, et al., &amp; Täuber, U (1986). The retention of isoconazole in the skin after once or twice daily application of 1% isoconazole nitrate cream (Travogen) over a 14-day period. <i>Clinical and experimental dermatology</i> 11(4) 365–370. DOI:<a href=\"https://doi.org/10.1111/j.1365-2230.1986.tb00476.x\">10.1111/j.1365-2230.1986.tb00476.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3802568/\">https://pubmed.ncbi.nlm.nih.gov/3802568</a></p></li><li><p>Täuber, U (1987). Availability of isoconazole in human skin after dermal application as free base and as nitrate in vitro. <i>Arzneimittel-Forschung</i> 37(4) 461–463. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3606700/\">https://pubmed.ncbi.nlm.nih.gov/3606700</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Isoconazole;
